Clinical determinants of treatment failure in patients with pseudomyxoma peritonei.
Clinical determinants of treatment failure in patients with pseudomyxoma peritonei.
复制标题
腹膜假粘液瘤患者治疗失败的临床决定因素。
DOI：
10.1007/978-1-4613-1245-1_11
复制
发表时间：
1996
影响因子：
--
通讯作者：
Falah Shamsa
中科院分区：
文献类型：
--
作者：
Paul H. Sugarbaker;V. Fernández;Falah Shamsa
腹膜假性黏液瘤（PMP）是一种非转移性局部持续性癌症，起源于胃肠道粘液上皮肿瘤，通常发生在阑尾或结肠。该临床综合征的特点是原发性肿瘤具有低恶性潜能，可导致粘液性肿瘤沉积物广泛扩散至整个腹部和骨盆。最近Sugarbaker等人和Zahn等人描述了其特征性的临床综合征和组织病理学[1,2]。
Pseudomyxoma peritonei (PMP) is a nonmetastasizing locally persistent cancer that arises from a mucinous epithelial tumor of the gastrointestinal tract, usually the appendix or colon. The clinical syndrome is characterized by a primary tumor of low malignant potential that causes extensive spread of mucinous tumor deposits throughout the abdomen and pelvis. It has a characteristic clinical syndrome and histopathology that have recently been described by Sugarbaker et al. and by Zahn et al. [1,2].